Diet : Microbe interactions - ecosystem support by Tuohy, K.M.
  Maria Jenmalm
  Dept of Clinical and Experimental Medicine, AIR, Faculty of Health Sciences, Linköping University, SE-581 85 Linköping, Sweden
  Tel: +46 10 103 41 01 e-mail: maria.jenmalm@liu.se
  My research focuses on childhood immune and allergy development in relation to maternal immunity and microbial exposure. I 
  am an immunologist collaborating with paediatric allergologists, obstetricians, clinical immunologists and microbiologists. Our 
  research is translational, combining advanced laboratory methodology with careful, long-term, clinical follow-up during 
  pregnancy and childhood with excellent compliance rates, also in randomised placebo-controlled intervention studies (see e.g. 
  ClinicalTrials.gov Identier NCT01542970). In my laboratory at the Division of In ammation Medicine at Linköping University, 
  Sweden, we analyse systemic and mucosal immune function by ELISA, Luminex,  ow cytometry, real time PCR and EILA (epigenetic
   immune lineage analysis). 
The role of the infant gut microbiota in shaping immune and allergy development during childhood
The increasing allergy prevalence in a!uent countries may be caused by reduced intensity and diversity of microbial 
stimulation, resulting in an abnormal postnatal immune maturation. The gut microbiota is quantitatively the most 
important source of microbial stimulation and may provide a primary signal for appropriate immune development. 
While no specic microbes with consistently harmful or allergy protective roles have yet been identied, the gut 
microbiota di"ers in composition and diversity during the rst months of life in children who later do or do not develop 
allergic disease. Early establishment of a diverse gut microbiota may be more important than the distribution of specic 
microbial species in shaping a normal immune maturation. It is also becoming increasingly evident that the maternal 
microbial environment during pregnancy is important in childhood immune programming. A combined pre- and 
postnatal supplementation seems to be crucial for the preventive e"ect of probiotics on infant eczema. Probiotic 
interventions have so far failed to prevent asthma, however. Further studies on the appropriate timing of interventions 
and the complex interactions between the infant immune system and the gut microbiota are required to identify 
preventive strategies to combat the asthma and allergy epidemic.
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Diet : Microbe interactions - ecosystem support
Recent metagenomic studies are conrming what pioneers in gut microbiology have long said, that diet:microbe 
interactions in the gut impact on human health and disease. The gut microbiota appear to regulate various physiological 
functions including host energy metabolism, immune homeostasis, and brain development and function. The gut 
microbiota produces a range of biologically active metabolites, not least, short chain fatty acids,  small phenolic 
compounds derived from polyphenol metabolism, and, immunologically and neurologically active amino acid 
derivatives such as gamma-aminobutyric acid, serotonin and dopamine. Microbiota activities also control systemic 
tryptophan metabolism and peripheral concentrations of potentially harmful metabolites derived from choline and 
carnitine metabolism, notably the cardiotoxicant trimethylamine-N-oxide. The gut microbiota also determines the 
prole of bile acids returning to the liver through the enterohepatic circulation, important cell signalling molecules 
involved in various physiological functions, including host energy metabolism and immune function. Diet in large part 
regulates these important microbiota physiological services and dietary constituents, particularly the relative 
proportions of fermentable ber and plant polyphenols on the one hand, and rened sugars, fat and animal protein, on 
the other, appear to critically determine the  ux of either benecial or potentially harmful metabolites from the gut. 
This presentation will discuss how diet regulates both the composition and metabolic output of the gut microbiota 
constituting, in e"ect, ecosystem support, not just for the gut microbiota, but for the greater human:microbe ecosystem 
as a whole. 
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